Omnes Capital's investments

Sector 
Pharma
Entry Date 
2019
Business 
Venture Capital

NH TherAguix

Nanomedicine for cancer radiotherapy
Founded in December 2015, and backed by Pulsalys, the technology transfer acceleration company from Lyon Saint-Etienne, NH TherAguix originates a nanomedicine innovation, the AGuIX drug candidate. This product, thanks to its nanometric structure, allows an IV administration and combines three essential attributes to fight tumours: targeting, imaging and treatment. The AGuIX technology is therefore part of the theranostics concept, which relates to a combination of therapy (radiosensitizing effect) and diagnostics (MRI imaging), and more widely in the personalized medicine of tomorrow.
Latest news
Sector 
Pharma
Entry Date 
2019
Business 
Venture Capital

AgomAb Therapeutics

A biotherapeutics company developing agonistic antibodies for regeneration of damaged tissues

AgomAb was founded through a collaboration between argenx and the University of Torino, Italy, based on the groundbreaking work of Paolo Michieli and his translational medicine team. The Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues and has produced a comprehensive preclinical package illustrating different applications in the fields of fibrotic, inflammatory, autoimmune and degenerative diseases. Based in Ghent Belgium, it is backed by an International syndicate of experienced life sciences venture capital investors.

Latest news
Sector 
Medical devices
Entry Date 
2019
Business 
Venture Capital

Therapixel

Artificial intelligence applied to radiology
Created in 2013 by two former INRIA researchers, Therapixel is a world leader in artificial intelligence applied to radiology. Winner of the DREAM Digital Mammography Challenge in 2017, Therapixel is developing an AI-based service for assisting radiologists review screening mammography for breast cancer.
Latest news
Sector 
Web
Entry Date 
2019
Business 
Venture Capital

Teach on Mars

Europe’s leading mobile-native learning technology provider

Teach on Mars is a 100% mobile-native learning technology provider. Our solution helps today’s organisations connect people with the learning and the communities they need to do their jobs and live their lives better. Winner of numerous industry awards, Teach on Mars is recognised as European leader in the mobile learning space. Since its foundation in 2013, the company has delivered its solution to over 100 blue-chip clients, in 20+ languages across more than 60 countries throughout the globe, and today it has bases in Sophia-Antipolis, Paris, Milan and London. 60 Teach on Mars staff and an extensive worldwide network of 40+ content and technology partners collaborate to equip organisations with the toolset, mindset and skillset required to create their next-generation learning ecosystem. And because Teach on Mars takes its responsibility for the future of our planet seriously, it invests 1% of its revenues in education projects contributing directly to the UNESCO Sustainsable Development Goals.

Latest news
Sector 
SaaS / Cloud
Entry Date 
2018
Business 
Venture Capital

Sentryo

Pioneer of Industrial Internet cybersecurity solutions
Sentryo helps organizations embrace the promises of Industry 4.0 innovations by keeping their industrial operations safe from cyber-attacks. Sentryo’s ICS CyberVision award winning platform gives control engineers comprehensive visibility on their industrial control systems, detects anomalies and accelerates response to cybersecurity incidents keeping them ahead of cyber threats.
Latest news
Sector 
Web
Entry Date 
2018
Business 
Venture Capital

GEEV

The first app for donating items between individuals

Thanks to a simple and fun service, "Geevers" can easily give and receive items for free in the proximity of their own homes. Available in Paris, Lyon, Marseille, Lille, Bordeaux, Nantes and Toulouse, GEEV has become an obvious alternative to selling, unnecessary storage and the proliferation of waste in the public space.

Latest news
Sector 
Pharma
Entry Date 
2018
Business 
Venture Capital

Antabio

Biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs

Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. Two of Antabio’s programs have received Wellcome Trust Seeding Drug Discovery Awards to date: [i] a novel, safe and efficacious inhibitor of bacterial metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections and [ii] a first-in-class inhibitor of Pseudomonas virulence to be co-administered with standard-of-care antibiotics for the long-term management of chronic respiratory infections. This second program has recently received up to $8.9 million funding from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). 

Latest news
Sector 
SaaS / Cloud
Entry Date 
2018
Business 
Venture Capital

Tiller

Tiller is the French leader in cash registers and connected management. Spanning 5,000 customers in more than 35 countries, Tiller offers a comprehensive management tool (order taking, cashing, real-time performance monitoring, integrated digital solutions marketplace) for merchants. With a team of nearly 150 people, offices in Paris, Barcelona and Milan, Tiller began its phase of hyper growth over a year ago and has now reached profitability.
Latest news
Sector 
Construction and building materials
Entry Date 
2018
Business 
Venture Capital

Nanomakers

Founded in 2010 and based in Rambouillet, the French start-up Nanomakers has been designing and producing since 2012 patented silicon-based nanopowders which transform the mechanical, chemical or thermal properties of materials. Its disruptive technology has made it possible to triple the energy density of Li-ion batteries anodes, or to lighten and reinforce the mechanical properties of certain materials (metal alloys, elastomers) used in various industrial sectors.
Latest news
Sector 
Hardware
Entry Date 
2018
Business 
Venture Capital

Tilkee

Tilkee was founded by Sylvain Tillon and Timothée Saumet in decembre 2013. The company offers a complete suite of document tracking solutions: Tilkee for Sales, Tilkee for Marketing, Tilkee for Jobs and Tilkee for Events. Tilkee currently employs 24 people and is growing in Europe (Germany, United Kingdom, Spain). Tilkee’s clients include EDF, Orange, Schneider Electric, Credit Agricole and Adecco

Latest news

Pages

NewsRoom
Press release
11 April 2019
NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance

NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance
Logo reveal video
Publication
Scope, the Omnes review, November 2018
Press release
09 April 2019
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Job offer
Discover our job offers on Linkedin
4 years 1 month ago
Le Cercle Omnes des Entrepreneurs - January 31, 2018
Press release
03 April 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
AgomAb Therapeutics Completes Euros 21m Series A Financing

Pages